Salome Mekhuzla: Representing WFH’s Voice in Front of WHO Leadership and National Governments
Salome Mekhuzla, Director of Global Development at the World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Read the WFH open letter to the WHO Director-General in support for the draft resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders here!
This landmark resolution is scheduled to be discussed at the 158th session of the WHO Executive Board, February 2nd, tentatively in the afternoon central european time, so morning hours for those in EST time zone. The WFH will be participating at this session and we will deliver a statement to represent our global community’s voice in front of WHO leadership and national governments!
Keep an eye on our social media posts on Monday, as we will share a web link for anyone interested to follow this discussion live.”
Quoting World Federation of Hemophilia’s post:
“The World Federation of Hemophilia has formally presented a letter to the WHO Director-General, urging support for a World Health Assembly resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders.
This global call highlights the ongoing gaps in diagnosis, treatment, and care, and the urgent need for coordinated action so access to care no longer depends on where someone lives.
The draft resolution is tabled for discussion at the 158th Session of the WHO Executive Board (EB158) in Geneva during February 2 to 7, 2026. The WFH commands leadership of WHO Member States in driving this resolution adoption process: Armenia as lead Member States, and co-sponsored by Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo. The WFH also thanks all member and partner organizations who have joined the WFH’s Global Call for Health Equity for Bleeding Disorders in support of the landmark resolution.
More posts featuring Salome Mekhuzla.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch